Long-term follow-up of patients with chronic total coronary artery occlusion previously randomized to treatment with optimal drug therapy or percutaneous revascularization of chronic total occlusion (COMET-CTO)

Long-term follow-up of patients with chronic total coronary artery occlusion previously randomized to treatment with optimal drug therapy or percutaneous revascularization of chronic total occlusion (COMET-CTO)

BackgroundThe COMET-CTO trial was a randomized prospective study that assessed long-term follow-up in patients with chronic total occlusion (CTO) in coronary arteries treated with percutaneous coronary intervention (PCI) or with optimal medical therapy (OMT). During the 9-month follow-up, the incide...

Full description

Bibliographic Details
Main Authors: Stefan A. Juricic, Sinisa M. Stojkovic, Alfredo R. Galassi, Goran R. Stankovic, Dejan N. Orlic, Vladan D. Vukcevic, Dejan G. Milasinovic, Srdjan B. Aleksandric, Miloje V. Tomasevic, Milan R. Dobric, Milan A. Nedeljkovic, Branko D. Beleslin, Miodrag P. Dikic, Marko D. Banovic, Miodrag C. Ostojic, Milorad B. Tesic
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
percutaneous coronary intervention
chronic total occlusion
optimal medical therapy
outcomes
long-term follow-up
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1014664/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.1014664/full

Similar Items